An update on ColaLife 15/11/12

ColaLife briefing for PATH International Conference on ORS and Zinc, 15 November 2012, Lusaka, Zambia.

3

The business model

2

The productOur starting points

1

Where we are now

4

What next?

5

The business model The productOur starting points

1

Where we are now What next?

2

4

3

5


If we can get fast moving consumer goods to remote rural areas, why can’t we do the same thing for essential medicines?

1Remote rural retail shop, Kalomo District, Zambia

Drug store room, Tiriri Health Centre, Katine, Uganda

The policy context for ColaLife (1). Policy-makers, technical experts and health practitioners know what works but have difficulty sustaining delivery.

1

Market-based solutions are often the most effective way to deliver key diarrhoea control commodities

Strengthened distribution systems and new delivery strategies

Diarrhoea treatment kits for all new mothers

New communication strategies

“

”WHO/UNICEF, 2009

The policy context for ColaLife (2). Under 5 mortality in the UK is around 1 in 200.

1

The policy context for ColaLife (2). Under 5 mortality in sub-Saharan Africa is 1 in 8.

1

The policy context for ColaLife (3). Diarrhoea is a key contributor to child mortality in sub-Saharan Africa.

1

The policy context for ColaLife (4). Current progress towards increasing survival rates is too slow. Innovation is needed – the status quo is not sufficient by itself.

1

The policy context for ColaLife (4). At the current rates of progress it will take more than 150 years to child mortality to fall to the levels in the UK today.

1

Our initial focus was the use of unused space in Coca-Cola crates as a delivery mechanism, but we have gone on to create an ‘end-to-end’ value chain: using Coca-Cola’s techniques and advice; using their wholesalers, who are well known in rural towns and have good warehousing and inventory control practices.

So far none of our registered retailers have used this technique to transport Kit Yamoyos.

1



2

4

31

5


We have designed a 4g/200ml sachet of ORS for the home treatment of diarrhoea and this is now being manufactured in Zambia. We believe this is an ‘Africa first’. A mother using a 20g/1litre sachet (and following the instructions) would throw most of it away.

2

Kit Yamoyo assembly at Pharmanova in Lusaka, Zambia.

2

Packing of kits into cartons at Pharmanova for delivery to Medical Stores Limited.

2

We are paying the para-statal, Medical Stores Limited, who are seeking to become ‘more private sector’, to deliver Kit Yamoyos to Coca-Cola wholesalers in Katete & Kalomo districts.

2

Kit Yamoyo cartons in stock at a Coca-Cola wholesaler. Wholesalers purchase the kits from the project and make a 20% profit on sales to retailers.

2

Retailers buy Kit Yamoyos from the general wholesaler (who is also the Coca-Cola wholesaler) when they visit the district town for other supplies. Using a Coca-Cola wholesaler helps guarantee quality as wholesalers are required by contract to carry out good warehousing and inventory practices. In addition, all retailers know where the Coca-Cola wholesaler is.

2

Kit Yamoyos for sale on the shelves in remote rural retail shops. Retailers make a profit of 35% on the sale of Kit Yamoyos but care-givers get a product the majority can afford. The project thus creates an end-to-end value chain with profits for entrepreneurs along the way.

2

Care-givers get reliable access to a life-saving product close to home.

2

ColaLife uses mobile phones to: provide an authentication system for the Kit Yamoyos; to deliver a Special Offer (50% off your next purchase); to allow promoters to activate vouchers before distribution and for voucher redemption by retailers.

2

The Kit Yamoyo is an innovative product. The packaging is a measure for making the ORS, it is a mixing device, a storage device and a cup. The ORS sachets make up an amount of ORS that is appropriate for the home treatment of diarrhoea.

2



2

4

31

5


3• Attractive• Affordable• Micro-porous, waterproof, tamper evident

sealing film• Branding carried on the instruction leaflet• SMS-based authentication• Contents based on a proven combined therapy

for diarrhoea treatment (ORS + Zinc)• Soap added to carry the prevention message• 4g/200ml ORS sachets (for home treatment)• Packaging is also:

• A measuring device for the water• A mixing device• A storage device (the soap tray is a lid)• A cup• And can be re-used

The product: Kit Yamoyo For a video demonstration of the kit in use please see:>> http://youtu.be/C9w1IN2Gq0c

http://youtu.be/C9w1IN2Gq0c



2

4

31

5


Dec 2011

We are here

The trial timeline.

4



5

2

4

31


5

Our strategy is to generate robust evidence on the elements of our approach that work; encourage the big players (MoHs, CHAI, UNICEF etc) to incorporate these elements into their own programs. ColaLife does not have the capacity for global roll-out but could be catalytic in achieving this through multi-sectoral partnerships.

5

Contact informationSimon Berryproject manager | ColaLife Operational Trial Zambia (COTZ)founder and ceo | ColaLifem +260 (0)9755 72175e [email protected] sxberryw http://colalife.orgb http://colalife.org/blogl COTZ project office http://colalife.org/map

Photo creditsMenu slides: Option 2 – Elias Lungu; Option 3 – Simon Berry with graphic design by Guy Godfree; Option 5 – Claire WardSlide 3: Katine image – The GuardianSlide 10 and 20: Kit Yamoyo inset – Simon Berry with graphic design by Guy GodfreeSlide 14: Elias LunguSlide 16 and 18 – Claire WardAll others – Simon Berry

Health & Medicine

An update on ColaLife 15/11/12